AR045362A1 - Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona - Google Patents

Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona

Info

Publication number
AR045362A1
AR045362A1 ARP040102906A ARP040102906A AR045362A1 AR 045362 A1 AR045362 A1 AR 045362A1 AR P040102906 A ARP040102906 A AR P040102906A AR P040102906 A ARP040102906 A AR P040102906A AR 045362 A1 AR045362 A1 AR 045362A1
Authority
AR
Argentina
Prior art keywords
monometansulfonate
benzoxazolona
bifenil
ilmetil
piperazinil
Prior art date
Application number
ARP040102906A
Other languages
English (en)
Inventor
Gerrit Klein
Amstel Maria J L Terhorst-Van
Klaas Zwier
Irene Eijgendaal
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924088&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR045362(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of AR045362A1 publication Critical patent/AR045362A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Abstract

La presente se refiere a una forma polimórfica estable del compuesto monometansulfonarto de 7-[4-([1,1´-bifenil]-3-ilmetil)-1-piperazinil]-2(3H)-benzoxazolona (INNM mesilato de bifeprunox), un método para la preparación de dicha forma polimórfica y su uso en productos farmacéuticos, especialmente en productos farmacéuticos para el tratamiento de desórdenes psicóticos y enfermedad de Parkinson. Reivindicación 1: Un polimorfo cristalino de monometansulfonato de 7-[4-([1,1´-bifenil]-3-ilmetil)-1-piperazinil]-2(3H)-benzoxazolona, que exhibe un diagrama de difracción en polvo de rayos X que tiene los picos característicos expresados en grados 2q a aproximadamente 7,0, 9,3, 10,0, 12,5, 15,4, 16,7, 17,2, 17,4, 17,7, 18,7, 21,3, 22,2, 25,2, 27,2, 28,3, 28,8 y 30,1.
ARP040102906A 2003-08-18 2004-08-13 Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona AR045362A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102573 2003-08-18

Publications (1)

Publication Number Publication Date
AR045362A1 true AR045362A1 (es) 2005-10-26

Family

ID=34924088

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102906A AR045362A1 (es) 2003-08-18 2004-08-13 Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona

Country Status (26)

Country Link
EP (1) EP1656358B1 (es)
JP (1) JP2007502802A (es)
CN (1) CN100422159C (es)
AR (1) AR045362A1 (es)
AT (1) ATE499348T1 (es)
AU (1) AU2004265104B2 (es)
BR (1) BRPI0413617A (es)
CA (1) CA2536149C (es)
DE (1) DE602004031534D1 (es)
DK (1) DK1656358T3 (es)
EA (1) EA008182B1 (es)
ES (1) ES2361508T3 (es)
IS (1) IS8279A (es)
ME (1) MEP37108A (es)
MX (1) MXPA06001881A (es)
MY (1) MY139462A (es)
NO (1) NO20061265L (es)
NZ (1) NZ545415A (es)
PL (1) PL1656358T3 (es)
PT (1) PT1656358E (es)
RS (1) RS20060113A (es)
SI (1) SI1656358T1 (es)
TW (1) TWI336695B (es)
UA (1) UA85562C2 (es)
WO (1) WO2005016898A2 (es)
ZA (1) ZA200601399B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423040B2 (en) * 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
KR20090033871A (ko) * 2006-06-16 2009-04-06 솔베이 파마슈티칼스 비. 브이 비페프루녹스 및 ｌ-ｄｏｐａ를 포함하는 병용 제제
WO2008025781A1 (en) 2006-08-31 2008-03-06 Solvay Pharmaceuticals B.V. Bifeprunox doses for treating schizophrenia
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
US9556916B2 (en) 2013-03-15 2017-01-31 Whirlpool Corporation High performance adjustable juicer with whole foods feed chute and clutch mechanism
US9675101B2 (en) 2013-03-15 2017-06-13 Whirlpool Corporation High performance adjustable juicer with whole foods feed chute

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199801942T2 (xx) * 1996-03-29 2000-08-21 Duphar International Research B.V. Piperazin ve piperidin bile�ikleri.
IL127497A (en) * 1997-12-18 2002-07-25 Pfizer Prod Inc Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders
AU2003999A (en) * 1997-12-19 1999-07-12 Advanced Research And Technology Institute, Inc. Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof
AR034206A1 (es) * 2001-02-16 2004-02-04 Solvay Pharm Bv Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos

Also Published As

Publication number Publication date
AU2004265104A1 (en) 2005-02-24
TW200513462A (en) 2005-04-16
ZA200601399B (en) 2007-04-25
EP1656358B1 (en) 2011-02-23
TWI336695B (en) 2011-02-01
EA200600442A1 (ru) 2006-08-25
PT1656358E (pt) 2011-05-12
ATE499348T1 (de) 2011-03-15
SI1656358T1 (sl) 2011-06-30
DE602004031534D1 (de) 2011-04-07
JP2007502802A (ja) 2007-02-15
EP1656358A2 (en) 2006-05-17
CN1835935A (zh) 2006-09-20
EA008182B1 (ru) 2007-04-27
MXPA06001881A (es) 2006-05-17
PL1656358T3 (pl) 2011-07-29
CA2536149A1 (en) 2005-02-24
AU2004265104B2 (en) 2009-06-04
BRPI0413617A (pt) 2006-10-17
CN100422159C (zh) 2008-10-01
DK1656358T3 (da) 2011-05-30
NZ545415A (en) 2009-11-27
WO2005016898B1 (en) 2005-05-19
MY139462A (en) 2009-10-30
MEP37108A (en) 2011-02-10
WO2005016898A3 (en) 2005-04-07
IS8279A (is) 2006-01-31
CA2536149C (en) 2011-03-22
ES2361508T3 (es) 2011-06-17
NO20061265L (no) 2006-05-09
RS20060113A (en) 2008-09-29
WO2005016898A2 (en) 2005-02-24
UA85562C2 (en) 2009-02-10

Similar Documents

Publication Publication Date Title
MY138352A (en) Benzothiazole derivatives
NO20084853L (no) Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni
MX2007009372A (es) Nuevos compuestos ii derivados de 2-piridina como inhibidores de elastasa neutrofila.
JP2008513510A5 (es)
TW200621762A (en) Novel compounds
ECSP056194A (es) Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa
PT1874746E (pt) Derivados de 1-n-azacicloalquil-3-fenoxipropano úteis para a preparação de medicamentos psicotrópicos
UY29085A1 (es) Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes
FR2885129B1 (fr) Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation.
HRP20090569T1 (hr) Stabilni kristalni oblici bifeprunoks mesilata, oblici njihovog doziranja i postupak njihovog korištenja
TW200735878A (en) Pharmaceutical compositions
EA200971087A1 (ru) Фармацевтические композиции и способ лечения острой мании
CL2008003811A1 (es) Compuestos derivados de 4-aminopirimidina-2,6-disustituidos, antagonistas del receptor de histamina h4; proceso de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una enfermedad alergica, inmunologica o inflamatoria, o dolor.
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
HK1114516A1 (en) Substituted sulfoxide compounds, methods for preparing the same and use thereof
BRPI0607214A2 (pt) derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv
DE602006001590D1 (de) 7-(2-(4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isochinolin-besylatsalz, dessen herstellung und dessen therapeutische verwendung
CL2007002897A1 (es) Uso de un antagonista (sartan) del receptor 1 (at-1) de angiotensina ii para la preparacion de una composicion farmaceutica para el tratamiento de una enfermedad generalizada en gatos; metodo para la profilaxis o el tratamiento de una enfermedad en g
UY29134A1 (es) Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones
AR045362A1 (es) Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
BRPI0413500A (pt) compostos, processos para a sua preparação, composição farmacêutica que compreende os mesmos, utilização de um composto, métodos para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
FR2842525B1 (fr) Derives de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments et compositions pharmaceutiques les renfermant
DE50312523D1 (de) Pharmazeutische wirkstoffkombination sowie deren verwendung
UY28470A1 (es) Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-(4-(1,1¨-bifenil)-3-ilmetil)-1-piperazinil)-2-(3h)-benzoxazolona)
MXPA05012772A (es) Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina.

Legal Events

Date Code Title Description
FB Suspension of granting procedure